Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
Sinovac Biotech Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 541.64M |
| September 30, 2020 | 23.05M |
| June 30, 2020 | 21.23M |
| March 31, 2020 | 6.646M |
| December 31, 2019 | 2.753M |
| September 30, 2019 | 0.044M |
| June 30, 2019 | 0.085M |
| March 31, 2019 | -1.145M |
| December 31, 2018 | -11.88M |
| September 30, 2018 | 85.64M |
| June 30, 2018 | -3.025M |
| March 31, 2018 | -6.549M |
| December 31, 2016 | 13.88M |
| September 30, 2016 | 8.208M |
| June 30, 2016 | -4.974M |
| March 31, 2016 | 10.67M |
| December 31, 2015 | -1.922M |
| September 30, 2015 | -6.198M |
| June 30, 2015 | 2.261M |
| March 31, 2015 | -18.34M |
| December 31, 2014 | -6.294M |
| September 30, 2014 | 10.71M |
| June 30, 2014 | -2.539M |
| March 31, 2014 | 3.431M |
| Date | Value |
|---|---|
| December 31, 2013 | -0.63M |
| September 30, 2013 | 3.477M |
| June 30, 2013 | 3.613M |
| March 31, 2013 | 7.959M |
| December 31, 2012 | 6.979M |
| September 30, 2012 | 1.330M |
| June 30, 2012 | 4.572M |
| March 31, 2012 | 4.449M |
| December 31, 2011 | -0.2844M |
| September 30, 2011 | 2.303M |
| June 30, 2011 | 0.7666M |
| March 31, 2011 | -2.172M |
| December 31, 2010 | 9.053M |
| September 30, 2010 | -0.4487M |
| June 30, 2010 | -14.02M |
| March 31, 2010 | 63.61M |
| December 31, 2009 | -3.083M |
| September 30, 2009 | -5.902M |
| June 30, 2009 | 16.06M |
| March 31, 2009 | -1.780M |
| December 31, 2008 | 2.606M |
| September 30, 2008 | -1.265M |
| June 30, 2008 | 0.112M |
| March 31, 2008 | 6.865M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
0.044M
Minimum
Sep 2019
541.64M
Maximum
Dec 2020
85.06M
Average
6.646M
Median
Mar 2020
Cash from Financing (Quarterly) Benchmarks
| CASI Pharmaceuticals Inc | -- |
| Zai Lab Ltd | 0.393M |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |